CONTEXT THERAPEUTICS INC.
CNTXCIK 0001842952
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$31.78M
−35.2% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.33
+17.4% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$26.62M
Q1 May 2026
Cash
$54.53M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
91.88M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.